Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Small buys trickling in, as usual no sellers about at these prices. Level 2 still very positive at 3 v 1.

Last batch of T10 traders from 6 August when the NHS RNS was announced have to settle tomorrow, hence 3 MMs sat on the 6.25 pence bid, why pay them more when the T10s have to close their positions.

Level 2 closed very positive at 3 v 1.


Their presentation to the NHS is to try and get the message across to the NHS of the effectiveness of the Nightingale system which the NHS need to include along with other measures which they need to use to prevent the MRSA problems.As the MRSA problems can be overcome through tackling cleaniness in many ways the NHS need to include as many methods as possible as only one method will not prevent the problem totally.

"The Nightingale technology has been used by hospitals internationally and two units have recently been acquired by North Hampshire Hospital in Basingstoke. Ian De Bruin, Project Director of the Estates Department for the hospital explains how they are currently being used: "North Hampshire currently has two Nightingale systems, one of which is used in the haematology unit, in the area where chemotherapy is performed and where immuno-compromised chemotherapy patients are present. The second is currently kept mobile and may be used in any part of the hospital. We plan to later move the units and use them permanently in the new isolation rooms of the haematology and oncology units at NHH, which are currently under construction.
The systems were picked up as a preventative measure for immunocompromised
patients, to keep their areas as clean as they can possibly be."

for more info see http://www.energytechniqueplc.co.uk/pdfs/UVGI/case%20study2.pdf
It's very encouraging to see that this (NHS) hospital is already planning to retain these units and "use them permanently in the new isolation rooms of the haematology and oncology units at NHH".
Other NHS hospitals are very likely to follow suit in due course in my opinion, it's just a matter of time.

More US sales may follow suit as well :

NQ has been granted a period of exclusivity to 30 September 2004, to enable it
to explore opportunities for marketing the Nightingale unit in the US and
Canadian markets. The Nightingale was exhibited by NQ at a commercial trade
show in the USA in June where interest was very encouraging. The initial sale
in the USA of product using Nightingale technology was achieved in July 2004 to
the Northwest Hospital Center in Randallstown, Maryland.

Hampshire Business South :

Technology - We have the weapon to fight superbug

A HAMPSHIRE company claims to have developed a lifesaving weapon in the fight against the lethal MRSA superbug.

But bosses of Energy Technique Plc say no one in the NHS is interested, despite its potential to prevent heartache for families across the south.

They claim the innovative 6,000 ultraviolet light device will destroy the killer bug but NHS money-men have pleaded poverty, although their American counterparts snapped it up.

The superbug hit the headlines earlier this week when new government figures showed 300,000 cases last year, more than three times as many as initially feared.

As reported in the Daily Echo this week, the number of hospital-acquired MRSA infections at Southampton University Hospitals NHS Trust rose from 53 cases in 2002-03 to 62 in 2003-04 up 17 per cent.

Experts calculate hospital infections kill up to 5,000 people each year in the UK with Methicillin Resistant Staphylococcus Aureus (MRSA) a prime cause.

Called the NightingaleR Unit, the UV device passed tests at Basingstokes North Hampshire Hospital.

The hospitals Ian De Bruin said: The UVGI systems appear capable of dealing with many airborne pathogens on a regular or emergency basis, which is certainly important when dealing with patients with weakened or non-existent immune systems.

The system is an easily serviceable piece of kit, and you dont need to do major intervention in the room with it being moveable.

Leigh Stimpson, group managing director of the former Southampton company which employs 120 people, is disappointed by the NHS response. He said: It is very sad that this sophisticated equipment, which is on sale to the NHS, has gone first to North America.

It is costing the NHS 1 billion a year to control MRSA, and instead of spending money on trying to prevent it in the first place, it is being used to try and deal with it after it has got into hospitals.

A Department of Health spokesman said it was up to trusts to decided if a product like this was suitable.

http://www.nqsouthern.com/digitalpublication/digitalpublications/index.cfm?dpid=144&section_id=1122&article_id=2550

Im afraid sue this is typical of the NHS and the Goverments way of conducting Business.It simply proves where their priorty lies. They waste millions on war / illegal immigrants etc.If the local Hospital cannot afford a Nightingale then they dont get and patients continue to suffer.The goverment will only begin to take action when it becomes political. Public start to sue the NHS. I heard on the radio yesterday that a fairly famous sportsman had become infected with mrsa after a routine operation.

The NHS tried to impliment a new pay structue, employed a lot of new staff to get it working tried it in two hospitals found it would not work so they scraped it at cost milions to the health service.

Why are some people positve on one batch of boards but on an another company's they a re negative.?

firm offer now at 6.55p expect the bid to be lowered to 6p .

MM s just play with the punters

Level 2 closed at 2 v 2. I think WINS orchestrated the drop as T10 traders which I have highlighted about previously had to close their positions today. It was all buying until the afternoon and a large buy for around 147,000 shares also came through at 6.74 pence. WINS offered 6.00 pence to a seller of 100K shares and the offer moved to 6.75 pence. I think WINS did this to get the sellers out as sellers which they may have expected today weren't coming. Immediately, WINS moved back onto the 6.25 pence bid to collect all the stock that came from the sellers, not that there was much. In line with my previous posts at these prices again there were few miniscule sells even with these actions. Level 2 actually went positive at that point to 2 v 1 but the sells were still not coming and hence I think EVO moved onto the offer of 6.75 pence and after that Level 2 was 2 v 2. Though not even one sell came through thereafter after the last small sell at 4.10pm. Trades at 6.45 for 35K, 30 K at 6.49 pence were buys. In addition, WINS & MLSB have been filling the large buys over the last week and not suprisingly both them are on the bid taking in stock.

Mystified....one just has to look at how all the large buys have come through over the last week and the size of the sells.

We last saw similar actions in the last hour prior to the buy note that came out from Evolution Beeson Gregory and day before when the NHS RNS was released.

I am holding onto all of mine, the NHS presentation is less than 2 weeks away now.

Investtech Analysis after today's close :

Positive Candidate (Short term) - Aug 19, 2004
Has broken through the floor of a rising trend channel. This indicates a slower rising rate at first, or the start of a more horizontal development. The stock has support at p 5.10 and resistance at p 7.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This weakens the trend break. The stock is overall assessed as technically positive for the short term.

Neutral (Medium term) - Aug 19, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

------------The RSI curve shows a rising trend, which is an early signal for a possible trend break up. This bit is new and has appeared after today's close

Weak Positive Candidate (Long term) - Aug 19, 2004
ENERGY TECH. ORD 1P does not show any clear trend. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock is testing the resistance at p 6.80. This should give a negative reaction, but an upward breakthough of p 6.80 means a positive signal. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which strengthens the stock. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

----------- but an upward breakthough of p 6.80 means a positive signal. This bit is new as well after today's close.

Sue , whats 4.95p x 40% ????

Liar.

Dil, why are you always attacking Sue Helen, is it an obsession?.

cheers GF.

Cos she lies and avoids answering any direct questions in my experience gf so fair game as far as I'm concerned gf.

My turn now , why are you always defending her when you know the above statement to be true ?

Have a good day , catch you in morning.

Just cant see what you find so wrong with her stock picking. Ive always found it to be first class.

Sure your not jealous?.

cheers GF.

Which bit of my previous post did you not understand gf ?

Hey Dildo head,

why dont u look at Sue stock picking choices.... she always stated when she is in and when she is out of the stock. i dont know where u get she lies. Advise: leave this thread

As one of her side kicks you wouldn't really would you.

What a load of tripe Dil, pretty sad.

More large buys : Large buy for 154,000 shares has just come through from an hour ago at 6.45 pence. WINS moved back onto the bid after that. Level 2 at 2 v 2.

Which bit Sue ?

And as I have nothing against this company , on the face of it they don't look bad , I will stick to the QTR thread as you asked so nicely xmortal.